KEPPRA XR 750 MG TABLET

levetiracetam
$13.5166per EA
High Outlier

Strength

750 mg/1

Manufacturer

UCB, Inc.

NDC

50474059966

Classification

Brand

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

LEVETIRACETAM

Approval Type

New Drug (NDA)

FDA Application

NDA022285

On Market Since

4/1/2009

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.5%

1Y

+2.5%

3Y

+9.9%

5Y

+24.4%

All

+79.3%